MEIRAGTX

Serial Number 99023559
641

Registration Progress

Application Filed
Jan 30, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Oct 21, 2025 79 days

Trademark Image

MEIRAGTX

Basic Information

Serial Number
99023559
Filing Date
January 30, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Jul 21, 2025
Application
Pending
Classes
001 005 040 042

Rights Holder

MeiraGTx Limited

16
Address
92 Britannia Walk
London N17NQ
GB

Ownership History

MeiraGTx Limited

Original Applicant
16
London GB

Legal Representation

Attorney
Michael J. Leonard

USPTO Deadlines

Next Deadline
79 days remaining
Non-Final Action Mailed
Due Date
October 21, 2025
Extension Available
Until January 21, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

7 events
Date Code Type Description Documents
Jul 21, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 21, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 21, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 10, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 1, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 30, 2025 NWAP I NEW APPLICATION ENTERED Loading...
Jan 30, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...

Detailed Classifications

Class 001
Chemical additives, namely, chemical auxiliary agents, carriers and substances for use in the manufacture of pharmaceutical preparations
Class 005
Pharmaceutical products for use in gene therapy; pharmaceutical preparations and substances; auxiliary agents, carriers and substances for pharmaceutical preparations; biological preparations for medical purposes.
Class 040
Custom manufacture of human therapeutics, pharmaceuticals, biologicals and biopharmaceuticals
Class 042
Scientific research in the field of genetics, gene therapy and genetic engineering; Genetic testing for scientific research purposes; scientific advisory services relating to gene therapy research; Scientific, biological, pharmaceutical and medical research and services; laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; biochemical and biotechnological analysis and services

Classification

International Classes
001 005 040 042